Brelung

Brelung is a combination inhaler containing Beclometasone Dipropionate and Formoterol Fumarate Dihydrate. It is used for managing asthma and chronic obstructive pulmonary disease (COPD). This medication helps control symptoms and prevent flare-ups.

Brelung is primarily used for the maintenance treatment of asthma and COPD. The Beclometasone Dipropionate component is a corticosteroid that reduces inflammation in the lungs, while Formoterol Fumarate Dihydrate is a long-acting beta-agonist that helps open the airways. This combination is often prescribed to manage symptoms and improve breathing. People often ask, 'What is Brelung used for?' and the answer is that it is designed to control and prevent symptoms of asthma and COPD.

Common effects of Brelung may include throat irritation, hoarseness, and a dry mouth. Some users might experience tremors, headaches, or an increased heart rate. These effects are generally mild and temporary. If any severe or persistent effects occur, it is important to consult a healthcare professional.

Brelung should be used as directed by a healthcare professional. It is important to rinse your mouth after each use to reduce the risk of throat irritation and fungal infections. Do not exceed the prescribed dose. People with certain medical conditions, such as heart disease or diabetes, should use this medication with caution.

Brelung may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all the medications you are taking. Additionally, avoid using this inhaler with other long-acting beta-agonists unless directed by a healthcare professional.